Heat Biologics, Inc. (NASDAQ: HTBX) is a clinical-stage biopharmaceutical company focused on developing its new “off-the-shelf” ImPACT therapeutic vaccine to combat a wide range of cancers. The company’s ImPACT Therapy is designed to deliver live, genetically-modified irradiated human cells which are reprogrammed to disperse a broad spectrum of cancer-associated antigens together with a potent immune adjuvant in order to educate and activate cancer patients’ immune systems to kill cancerous cells. For more information, visit the company’s website at www.heatbio.com.

Noble Financial Capital Markets, an equity research driven, full-service, investment banking boutique, is hosting its tenth annual equity conference in Sandpiper Bay, FL. Attended by institutional investors from across North America, the event features more than 140 public company executive teams from a diverse range of industries. For more information, visit www.noble.missionir.com.